KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Overview Fund Activity
Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

89 hedge funds and large institutions have $372M invested in Chinook Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 14 reducing their positions, and 12 closing their positions.

Holders
89
Holders Change
+12
Holders Change %
+15.58%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
37
Reduced
14
Closed
12
Calls
$4K
Puts
$893K
Net Calls
-$889K
Net Calls Change
+$113K

Top Buyers

1
AC
1
Armistice Capital
New York
$17.5M
2
FM
2
Frazier Management
Washington
$15.5M
3
BlackRock
3
BlackRock
New York
$34.9M
4
CS
4
Candriam SCA
Luxembourg
$12.4M
5
State Street
5
State Street
Massachusetts
$13.3M

Top Sellers

1
VC
1
Vivo Capital
California
$12.3M
2
EC
2
EcoR1 Capital
California
$13.2M
3
Citadel Advisors
3
Citadel Advisors
Florida
$3.55M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$0
5
SFM
5
Sphera Funds Management
Israel
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
101
Concourse Financial Group Securities
Alabama
– – – –
PA
102
Parallel Advisors
California
$0 5 – –
1 2 3 4
5